{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:15:17Z","timestamp":1780492517540,"version":"3.54.1"},"reference-count":18,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p>Effective treatment of opioid use disorder (OUD) must target both the medical and psychosocial aspects of a patient's condition. This, in turn, requires a collaboration between medical providers and social supports. We would like to illustrate a key difficulty in this collaboration for some patients in our country: many post-discharge recovery houses continue to refuse to allow patients to remain on medication treatment for OUD (M-OUD). This barrier to M-OUD access in recovery houses is a significant obstacle to effective OUD treatment.<\/jats:p>","DOI":"10.1080\/08897077.2019.1695038","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T13:27:15Z","timestamp":1575466035000},"page":"11-13","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Persisting Gaps in M-Oud Coverage at Post-Discharge Recovery Houses Necessitate Our Continued Advocacy"],"prefix":"10.1177","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5398-2085","authenticated-orcid":false,"given":"Pious","family":"Patel","sequence":"first","affiliation":[{"name":"Vanderbilt University School of Medicine, Nashville, Tennessee, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Ramaswamy","sequence":"additional","affiliation":[{"name":"Vanderbilt University School of Medicine, Nashville, Tennessee, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramzi","family":"Mardam Bey","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,1,1]]},"reference":[{"key":"e_1_3_5_2_2","volume-title":"2018 National Survey on Drug Use and Health (NSDUH):Methodological Summary and Definitions","author":"SAMHSA.","year":"2019","unstructured":"SAMHSA. 2018 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2019."},{"issue":"5152","key":"e_1_3_5_3_2","first-page":"1419","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2013\u20132017","volume":"67","author":"Scholl L","year":"2019","unstructured":"Scholl L, , Seth P, , Kariisa M, , Wilson N, , Baldwin G. Drug and opioid-involved overdose deaths\u2014United States, 2013\u20132017. Morbidity and Mortality Weekly Report. 2019;67(5152):1419.","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2010.10400705"},{"key":"e_1_3_5_5_2","volume-title":"Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Vol Report No.: (SMA) 12-4214","author":"CSAT. SAMHSA\/CSAT Treatment Improvement Protocols","year":"2005","unstructured":"CSAT. SAMHSA\/CSAT Treatment Improvement Protocols. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Vol Report No.: (SMA) 12-4214. Rockville, MD: Substance Abuse and Mental Health Services Administration (US), Center for Substance Abuse Treatment; 2005."},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0094-5"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1037\/0003-066X.46.11.1115"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.91.11.1842"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.13.1454"},{"key":"e_1_3_5_10_2","unstructured":"O'Brien J Sadwith T Croze C Parker S. Review of State Strategies to Expand Medication-Assisted Treatment: A Report to the Laura and John Arnold Foundation. Boston MA: Technical Assistance Collaborative; 2019."},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e3181d41ddb"},{"key":"e_1_3_5_12_2","volume-title":"Recovery Housing: Best Practices and Suggested Guidelines","author":"SAMHSA","year":"2019","unstructured":"SAMHSA. Recovery Housing: Best Practices and Suggested Guidelines. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2019."},{"key":"e_1_3_5_13_2","first-page":"1","volume-title":"MAT-Capable Recovery Residences: How State Policymakers Can Enhance and Expand Capacity to Adequately Support Medication Assisted Recovery","author":"NARR","year":"2018","unstructured":"NARR. MAT-Capable Recovery Residences: How State Policymakers Can Enhance and Expand Capacity to Adequately Support Medication Assisted Recovery. St Paul, MN: National Alliance for Recovery Residences; 2018:1\u201317."},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2011.01.032"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10597-017-0218-4"},{"issue":"6","key":"e_1_3_5_16_2","first-page":"3","article-title":"State responses to substance abuse among pregnant women","volume":"3","author":"Dailard C","year":"2000","unstructured":"Dailard C, , Nash E. State responses to substance abuse among pregnant women. Guttmacher Rep Publ Pol. 2000;3(6):3\u20136.","journal-title":"Guttmacher Rep Publ Pol."},{"key":"e_1_3_5_17_2","volume-title":"Medicaid Coverage of Medications for the Treatment of Opioid Use Disorder in Tennessee","author":"ASAM.","year":"2014","unstructured":"ASAM. Medicaid Coverage of Medications for the Treatment of Opioid Use Disorder in Tennessee. Rockville, MD: American Society of Addiction Medicine; 2014."},{"key":"e_1_3_5_18_2","unstructured":"Eyre E. Trump officials seek opioid solutions in WV. Charleston Gazette-Mail. May 9 2017."},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2017.1389802"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2019.1695038","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2019.1695038","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2019.1695038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:54:23Z","timestamp":1780491263000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2019.1695038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1080\/08897077.2019.1695038"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2019.1695038","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}